Moreover, in MM patients, the proportion of Th17 cells is correlated with the severity of bone lesions and in vitro, IL-17 stimulates the differentiation of bone-resorbing OCLs not only from BM cells (63) but also from DCs from MM patients (64). Here, IL17A is linked to Miyoshi myopathy.